Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO.

The APN possesses the advanced clinical knowledge and skills to be able to synthesize the assessment information and create a comprehensive plan -- including pharmacologic and nonpharmacologic ...

If you're looking for a Audi 80 you will definitely want to know all about every aspect of the car – and Parkers has all the spec details you need to know how it will fit into your life. Check out the ...